Literature DB >> 14609911

Cone dysfunction in patients with late-onset cone dystrophy and age-related macular degeneration.

Markus Ladewig1, Hannelore Kraus, Michael H Foerster, Ulrich Kellner.   

Abstract

OBJECTIVES: To determine the clinical and functional findings in patients with late-onset cone dystrophy (LOCD) (after the age of 50 years), which is rare; and to compare them with those of patients with age-related macular degeneration (AMD).
METHODS: Eleven LOCD patients underwent ophthalmologic and electroretinographic examinations. Full-field electroretinograms were recorded according to the International Society for Clinical Electrophysiology of Vision standard. The results were compared with those of a group of 20 AMD patients and a group of 23 age-related control subjects.
RESULTS: There was no difference between LOCD and AMD patients regarding the severity of visual acuity loss, color vision deficiencies, and central visual field defects. Alterations of the posterior pole were present in all LOCD and AMD patients. In contrast to the AMD group, all LOCD patients did not show drusen and 6 of the 11 LOCD patients displayed temporal optic disc pallor. The electroretinogram revealed the major functional difference, with severe reduction of cone-mediated responses and moderate reduction of rod-mediated responses in LOCD patients. Unexpectedly, the 30-Hz flicker amplitude was reduced in AMD patients compared with healthy controls.
CONCLUSIONS: Late-onset cone dystrophy and AMD have several features in common. In elderly patients with progressive visual loss and without drusen, LOCD should be considered. The electroretinographic results in a small group of AMD patients indicate a generalized cone dysfunction.

Entities:  

Mesh:

Year:  2003        PMID: 14609911     DOI: 10.1001/archopht.121.11.1557

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Senile panretinal cone dysfunction in age-related macular degeneration (AMD): a report of 52 amd patients compared to age-matched controls.

Authors:  Shawn Ronan; Steve Nusinowitz; Anand Swaroop; John R Heckenlively
Journal:  Trans Am Ophthalmol Soc       Date:  2006

2.  Late onset cone dystrophy.

Authors:  Ewa Langwińska-Wośko; Kamil Szulborski; Karina Broniek-Kowalik
Journal:  Doc Ophthalmol       Date:  2010-01-13       Impact factor: 2.379

3.  Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients.

Authors:  Focke Ziemssen; Matthias Lüke; Andre Messias; Julia Beutel; Olcay Tatar; Eberhart Zrenner; Karl U Bartz-Schmidt
Journal:  Int Ophthalmol       Date:  2007-07-20       Impact factor: 2.031

Review 4.  [Clinical findings and diagnostics of cone dystrophy].

Authors:  U Kellner; S Kellner
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

5.  Pinosylvin Extract Retinari™ Sustains Electrophysiological Function, Prevents Thinning of Retina, and Enhances Cellular Response to Oxidative Stress in NFE2L2 Knockout Mice.

Authors:  Toni Tamminen; Ali Koskela; Elisa Toropainen; Iswariyaraja Sridevi Gurubaran; Mateusz Winiarczyk; Mikko Liukkonen; Jussi J Paterno; Petri Lackman; Amir Sadeghi; Johanna Viiri; Juha M T Hyttinen; Ari Koskelainen; Kai Kaarniranta
Journal:  Oxid Med Cell Longev       Date:  2021-12-07       Impact factor: 6.543

Review 6.  Should clinical automated perimetry be considered for routine functional assessment of early/intermediate age-related macular degeneration (AMD)? A systematic review of current literature.

Authors:  Matt Trinh; Michael Kalloniatis; Lisa Nivison-Smith
Journal:  Ophthalmic Physiol Opt       Date:  2021-11-29       Impact factor: 3.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.